{"id":15795,"date":"2022-04-28T08:13:02","date_gmt":"2022-04-28T08:13:02","guid":{"rendered":"https:\/\/interhospi.com\/?p=15795"},"modified":"2022-04-28T08:13:02","modified_gmt":"2022-04-28T08:13:02","slug":"omnicell-introduces-ivx-station-robotic-compounding-technology","status":"publish","type":"post","link":"https:\/\/interhospi.com\/omnicell-introduces-ivx-station-robotic-compounding-technology\/","title":{"rendered":"Omnicell introduces IVX Station robotic compounding technology"},"content":{"rendered":"
\n

<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Omnicell introduces IVX Station robotic compounding technology<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Omnicell has launched their IVX Station, an innovative solution designed to scale the benefits of leveraging IV robotic technology, making it accessible to the mainstream market.\u00a0<\/span><\/p>\n

<\/p>\n

Omnicell\u2019s completely reimagined, fully automated IV compounding robot is designed to deliver the patient safety, accuracy, cost savings, supply chain control, and compliance benefits of its predecessors while addressing industry issues with throughput and reliability. IVX Station supports three times the throughput speed of current IV robotic technology, features a design focused on high reliability with a precision-machined super structure to eliminate the number one cause of downtime \u2013 re-calibration, and maintains the approximate footprint of a four-foot hood.\u00a0<\/span><\/p>\n

IVX Station is available through Omnicell\u2019s IV Compounding Service, which combines the technology with expertly trained pharmacy technicians and services in an effort to ensure value realization. This \u201cas-a-Service\u201d approach should help to reduce reliance on outsourced sterile compounding, while allowing health systems to reduce drug waste in the operating room.<\/p>\n

\u201cNearly a decade ago, University of Rochester Medical Center began a journey toward a fully autonomous approach to medication management as an early adopter of IV robotics technology,\u201d said David Webster, RPh, MSBA, director of acute care pharmacy operations at University of Rochester Medical Center. \u201cImproving quality and safety in compounding operations is a long-term strategic investment we made to enhance patient care and elevate the role of the pharmacy. We believe Omnicell\u2019s IVX Station will be a catalyst for driving operational and patient safety priorities, ultimately helping us advance technology-driven pharmacy operations.\u201d\u00a0<\/span><\/p>\n

Omnicell has strengthened its portfolio of intelligent infrastructure solutions for medication management with the following enhancements:\u00a0<\/span><\/p>\n